Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

MERCK & CO., INC.

(MRK)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector newsMarketScreener Strategies
All news about MERCK & CO., INC.
02:37aMerck & Co. Said to Seek Japanese Regulatory Nod for COVID-19 Pill
MT
02:01aMerck Applies for Covid Pill Approval in Japan, Nikkei Reports
DJ
01:18aTokyo stocks end higher on hopes for COVID-19 oral treatment drug
AQ
12/02U.S. FDA Accepts for Priority Review the Supplemental Biologics License Application for..
AQ
12/02Federal Court Of Appeal Dismisses Appeal, Upholds Strict Interpretation Of Patent Listi..
AQ
12/01GLOBAL MARKETS LIVE : Merck, Volkswagen, Salesforce, Roche, Mondelez...
12/01WALL STREET STOCK EXCHANGE : The Fed takes a new stance
12/01Merck & Company's Supplemental Biologics License Application for Vaxneuvance Gets FDA P..
MT
12/01Merck Gets FDA Priority Review of Vaxneuvance Vaccine in Children
DJ
12/01MarketScreener's World Press Review - December 1st, 2021
12/01U.S. FDA Accepts for Priority Review the Supplemental Biologics License Application for..
BU
12/01U.S. Food and Drug Administration Accepts for Priority Review the Supplemental Biologic..
CI
11/30US FDA Panel Recommends Merck & Co.'s COVID-19 Pill
MT
11/30Merck and Ridgeback Statement on Positive FDA Advisory Committee Vote for Investigation..
BU
11/30Merck and Ridgeback Statement on Positive FDA Advisory Committee Vote for Investigation..
CI
11/30Merck & Co. COVID-19 Pill Receives Recommendation From FDA Advisory Panel Despite Safet..
MT
11/30Merck & Company Lifts Q1 2022 Dividend to $0.69/Share From $0.65/Share, Payable Jan. 7 ..
MT
11/30Merck Announces First-Quarter 2022 Dividend
BU
11/30Merck Declares Divined for the First Quarter of 2022, Payable on January 7, 2022
CI
11/30Pharmaceutical Names to See Increased Volatility into Year End Amid Omicron Updates, Op..
MT
11/30Merck & Co. Exec Says COVID-19 Drug Likely To Be Effective Against Variants
MT
11/30MERCK THINKS COVID ANTIVIRAL HAS SIM : Reuters
MT
11/30WALL STREET STOCK EXCHANGE : Questions about Omicron and vaccine efficiency rattle markets
11/30Merck & Company's Keytruda Plus Chemotherapy Combination Approved in Japan for Initial ..
MT
11/30Merck Says Supplemental New Drug Application for Lynparza Accepted, Granted Priority Re..
MT
11/30Merck's KEYTRUDA« (pembrolizumab) Approved in Japan in Combination With Chemotherapy fo..
BU
11/30ASTRAZENECA : Lynparza Gets FDA Priority Review -- Update
DJ
11/30Japan Pharmaceuticals and Medical Devices Agency Approves Keytruda, Merck?S Anti-Pd-1 T..
CI
11/30FDA Accepts Regulatory Submission of Supplemental New Drug Application for LYNPARZA« (o..
BU
11/30AstraZeneca and Merck Announces FDA Accepts Regulatory Submission of Supplemental New D..
CI
11/30ANALYST RECOMMENDATIONS : Best Buy, Beyond Meat, Booking, Merck, Pfizer...
11/30Eisai Co - European Commission Approves LENVIMA (lenvatinib) Plus KEYTRUDA (pembrolizum..
AQ
11/30Eisai - European Commission Approves LENVIMA (lenvatinib) Plus KEYTRUDA (pembrolizumab)..
AQ
11/30AstraZeneca Breast Cancer Drug Accepted for Priority Review in US
MT
11/29Equities Rebound Midday From Omicron Selloff With Technology, Energy in Lead
MT
11/29SVB Leerink Adjusts Merck & Co.'s Price Target to $102 from $105, Keeps Outperform Rati..
MT
11/29WALL STREET STOCK EXCHANGE : Back to the guessing game
11/29Morgan Stanley Adjusts Merck & Co.'s Price Target to $82 from $88, Keeps Equalweight Ra..
MT
11/29Health Care Stocks Rally Premarket Monday
MT
11/29Merck and Ridgeback Biotherapeutics Provide Update on Results from MOVe-OUT Study of Mo..
AQ
11/29Merck Secures European Approval for Advanced Renal Cell Carcinoma Combo Therapy
MT
11/29Merck, Eisai Get Europe OK for Lenvima/Keytruda Combination in Two Cancers
DJ
11/29European Commission Approves KEYTRUDA« (pembrolizumab) Plus LENVIMA« (lenvatinib) for P..
BU
11/29European Commission Approves KEYTRUDA« (pembrolizumab) Plus LENVIMA« (lenvatinib) as Fi..
BU
11/29European Commission Approves KEYTRUDA? (pembrolizumab) Plus LENVIMA? as First-Line Trea..
CI
11/29ANALYST RECOMMENDATIONS : Asos, Burberry, Greif, Merck, Mirion Technologies....
11/29Citigroup Cuts Merck & Co. to Neutral From Buy, Price Target to $85 From $105
MT
11/26New Analysis Shows Merck COVID-19 Pill Molnupiravir Less Effective Than Previously Repo..
MT
11/26Merck & Co. Says Molnupiravir Cuts Risk of Severe COVID-19 Based on Trial Data
MT
11/26Merck, Ridgeback Biotherapeutics' Molnupiravir Drug Reduced Risk of Severe COVID-19 Bas..
MT
11/26Merck and Ridgeback Biotherapeutics Provide Update on Results from MOVe-OUT Study of Mo..
BU
11/26Merck and Ridgeback Biotherapeutics Provide Update on Results from MOVe-OUT Study of Mo..
CI
11/26UK To Test Merck & Co.'s COVID-19 Pill In National Study
MT
11/26Pfizer, Merck Reportedly Agree to License Production of Respective Experimental COVID-1..
MT
11/26Pfizer, Merck & Co. Set to Allow Vietnamese Companies to Produce COVID-19 Pill
MT
11/24Truist Securities Adjusts Merck's Price Target to $95 From $92, Reiterates Buy Rating
MT
11/24Merck to Present at the 4th Annual Evercore ISI HealthCONx Conference
BU
11/24Gilead Sciences, Merck Pause Phase 2 HIV Trial
MT
11/23MERCK : Gilead and Merck Announce Temporary Pause in Enrollment for Phase 2 Study Evaluati..
PU
11/23Merck & Co. Lands Health Canada's Conditional Approval for Keytruda Therapy to Treat Tr..
MT
11/23Merck's Keytruda Therapy Gets Conditional Health Canada Approval for Treatment of Tripl..
MT
11/23GLOBAL MARKETS LIVE : Samsung, Clariant, AstraZeneca, Amazon, Merck...
11/23Health Canada Approves Merck's Keytruda in Combination to Treat Certain Breast Cancers
DJ
11/23Health Canada Approves KEYTRUDA« (pembrolizumab) in Combination with Chemotherapy for t..
AQ
11/23Health Canada Approves KEYTRUDA? (pembrolizumab) in Combination with Chemotherapy for t..
CI
11/23WALL STREET STOCK EXCHANGE : The Fed cannot stop Covid
11/23Qurient Co. Ltd. Enters into A Clinical Collaboration Agreement with MSD
CI
11/22Merck Completes Acceleron Pharma Acquisition
MT
11/22Merck Completes Acquisition of Acceleron Pharma Inc.
BU
11/22Merck Completes Tender Offer to Acquire Acceleron Pharma Inc.
AQ
11/22Merck Completes Cash Tender Offer to Purchase Acceleron Pharma at $180/Share
MT
11/22Supplying Covid-19 Pills At Lower Cost Is Only Part of What Poorer Countries Need
AQ
11/19Merck Completes Tender Offer to Acquire Acceleron Pharma Inc.
BU
11/19Merck & Co.'s COVID-19 Pill Can be Used to Treat Certain Adults, EU Regulator Says
MT
11/19EU Regulator Says Merck's COVID-19 Pill Can be Used to Treat Certain Adults
MT
1  2  3  4  5  6  7  8  9  10Next
Upcoming event on MERCK & CO., INC.